Bedrocan is the only company in the world currently producing standardized, full-bud medicinal cannabis. Bedrocan produces for a number of international governments (Netherlands, Italy, Germany, Finland, Canada, and the Czech Republic) which make the medicinal cannabis available under special access conditions as an unapproved drug. Bedrocan strives to bridge the gap between patients' needs for cannabis and the quality standards of modern medicine. We do this through an active research program and a commitment to sharing our knowledge through scientific publication. We believe herbal cannabis can, and should, meet all of the existing regulations for medicines. In the Netherlands, Bedrocan produces medicinal-grade cannabis under contract for the Dutch Ministry of Health.